Login / Signup

Outcomes Associated With Levetiracetam Use After Spontaneous Intracerebral Hemorrhage.

Mary Stewart LeatherwoodLeslie A HamiltonJacob BarberAnthony Shaun Rowe
Published in: The Neurohospitalist (2023)
This study does not support the use of levetiracetam prophylaxis in patients who have experienced an ICH.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • type diabetes
  • adipose tissue